
Rodman & Renshaw
http://www.rodmanandrenshaw.com/Rodman & Renshaw is an investment bank. The firm provides investment banking services to companies that have significant recurring capital needs along with research, sales, and trading services to institutional investors. The firm focuses on the biotechnology sector and since 2003 has been a leading investment bank to the sector. The firm is also a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
View Older Stories
-
BioAmber (BIOA) Announces Underwritten Common Offering
-
Rosetta Genomics (ROSG) Prices of $2.73M Offering of Ordinary Shares and Warrants
-
StreetInsider.com Premium Hot Research Recap 7/26
-
Rodman & Renshaw Starts The Female Health Company (FHCO) at Buy
-
Plug Power (PLUG): Walmart Deployment Visibility Includes Equity Investment - Rodman & Renshaw
-
Kitov Pharma (KTOV) Prices 2.43M ADS Registered Direct Offering at $1.45/Sh
-
Kitov Pharma (KTOV) Reports 3.5M Registered Direct Offering of ADSs
-
UPDATE: Rodman & Renshaw Starts Fortress Biotech (FBIO) at Buy
-
Rodman & Renshaw Starts Jaguar Animal Health (JAGX) at Buy
-
Rodman & Renshaw Starts Aqua Metals (AQMS) at Buy
-
Rodman & Renshaw Starts American Silver Corp. (USAS) at Buy
-
Rodman & Renshaw Assumes Vical (VICL) at Buy
-
Eyegate Pharma (EYEG) Offers 6.67M in Common Stock and Warrants Priced at $1.50/Shares
-
UPDATE: Rodman & Renshaw Starts Aptose Biosciences (APTO) at Neutral, "Ready, Set, Now Just Need Clinic-Ready Drugs to Go"
-
Pre-Open Movers 05/30: (PTGX) (ATW) (XTLY) Higher; (AMBA) (WLL) (BWLD) Lower (more...)
-
Rodman & Renshaw Starts pSivida Corp. (PSDV) at Buy
-
UPDATE: Rodman & Renshaw Starts Pieris Pharmaceuticals (PIRS) at Buy
-
Emagin Corporation (EMAN) Announces $6.6M Offering of Common Stock, Warrants
-
MTBC (MTBC) Receives Gross Proceeds of $2.3M Following Direct Offering of Common Stock
-
UPDATE: Rodman & Renshaw Starts Lion Biotechnologies (LBIO) at Buy
-
Amyris (AMRS) Enters Agreements for $95M in Equity Financing; In-Process to Significantly Reduce Debt
-
AmpliPhi Biosciences (APHB) Prices 6.956M Share + Warrant Offering at $1.50/Sh
-
CEL-SCI Corp (CVM) to Sell 13.2M Shares at $0.115 in Registered Direct Offering
-
UPDATE: Rodman & Renshaw Starts Aduro Biotech (ADRO) at Buy, Sees Multiple Tracks Pushing ADRO To Core Biotech Holding
-
Rodman & Renshaw Starts Alimera Sciences (ALIM) at Buy
-
Rodman & Renshaw Starts Apricus Biosciences (APRI) at Buy
-
Rodman & Renshaw Starts Resonant (RESN) at Buy
-
NASH: The next untapped pharma market gives investors many options
-
Apricus Biosciences (APRI) Prices 5M Unit Offering at $1.40/Unit
-
Sorrento Therapeutics (SRNE) Prices 23.63M Common Stock Offering at $2/Share
-
SkyPeople Fruit Juice (SPU) Announces $2.67M Registered Direct Offering
-
Delmar Pharma (DMPI) Prices $9M Common Stock and Warrant Offering
-
Delmar Pharma (DMPI) to Offer Common Stock and Warrants
-
UPDATE: Rodman & Renshaw Assumes Celsion Corp (CLSN) at Buy
-
Pre-Open Movers 04/06: (SCON) (YUMC) (JAZZ) Higher; (SYNC) (CAFD) (AMD) Lower (more...)
-
UPDATE: Rodman & Renshaw Upgrades Superconductor Technologies (SCON) to Buy
-
Rodman & Renshaw Assumes Rexahn Pharmaceuticals Inc. (RNN) at Buy
-
Ohr Pharmaceutical (OHRP) Prices $14.175M Offering of Common Stock and Warrants
-
Ohr Pharmaceutical (OHRP) Reports Proposed Equity Offering
-
UPDATE: Rodman & Renshaw Starts BeyondSpring Inc. (BYSI) at Buy
-
Alliqua BioMedical (ALQA) Confirms Closing of $3.8M Share Offering
-
Pre-Open Movers 03/31: (SORL) (BBRY) (BDSI) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
After-Hours Stock Movers 03/30: (AKTX) (VJET) (HIIQ) Higher; (DRIO) (BLRX) (CTSO) Lower (more...)
-
Apricus Biosciences (APRI) files to offer up to $6.9 million in common stock through Rodman & Renshaw
-
Rodman & Renshaw Downgrades Exeter Resources Corp. (XRA) to Neutral
-
Alliqua (ALQA) Prices 9.38M Common Stock Offering at $0.40/Share
-
Alliqua (ALQA) Plans Offering of Common Stock
-
Rodman & Renshaw Reiterates Buy and $6 PT on Sophiris Bio (SPHS) Following 4Q EPS Beat
-
Rodman & Renshaw Starts EnSync Inc. (ESNC) at Buy
-
Medigus (MDGS) Prices ~980K Class A and ~1.2M Class B Units at $3.50